SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-118978
Filing Date
2022-04-26
Accepted
2022-04-26 08:30:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d315632ddefa14a.htm DEFA14A 10147
2 GRAPHIC g315632g33c13.jpg GRAPHIC 309585
3 GRAPHIC g315632g34d14.jpg GRAPHIC 175981
  Complete submission text file 0001193125-22-118978.txt   680223
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38443 | Film No.: 22851880
SIC: 2834 Pharmaceutical Preparations